These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11168980)

  • 1. 3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone.
    Niwa T; Tsukushi S
    Kidney Int Suppl; 2001 Feb; 78():S37-41. PubMed ID: 11168980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication.
    Niwa T
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):23-36. PubMed ID: 10491986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
    Tsukushi S; Katsuzaki T; Aoyama I; Takayama F; Miyazaki T; Shimokata K; Niwa T
    Kidney Int; 1999 May; 55(5):1970-6. PubMed ID: 10231461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
    Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
    Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.
    Li W; Hamada Y; Nakashima E; Naruse K; Kamiya H; Akiyama N; Hirooka H; Takahashi N; Horiuchi S; Hotta N; Oiso Y; Nakamura J
    Biochem Biophys Res Commun; 2004 Feb; 314(2):370-6. PubMed ID: 14733914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
    Takayama F; Aoyama I; Tsukushi S; Miyazaki T; Miyazaki S; Morita T; Hirasawa Y; Shimokata K; Niwa T
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1101-9. PubMed ID: 9846892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
    Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
    Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
    Hamada Y; Nakamura J; Naruse K; Komori T; Kato K; Kasuya Y; Nagai R; Horiuchi S; Hotta N
    Diabetes Care; 2000 Oct; 23(10):1539-44. PubMed ID: 11023149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.
    Niwa T
    Semin Dial; 2001; 14(2):123-6. PubMed ID: 11264780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients.
    Niwa T; Takeda N; Miyazaki T; Yoshizumi H; Tatematsu A; Maeda K; Ohara M; Tomiyama S; Niimura K
    Nephron; 1995; 69(4):438-43. PubMed ID: 7777110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone.
    Jono T; Nagai R; Lin X; Ahmed N; Thornalley PJ; Takeya M; Horiuchi S
    J Biochem; 2004 Sep; 136(3):351-8. PubMed ID: 15598892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of glycation and oxidative stress in diabetic macroangiopathy.
    Taniguchi N; Kaneto H; Asahi M; Takahashi M; Wenyi C; Higashiyama S; Fujii J; Suzuki K; Kayanoki Y
    Diabetes; 1996 Jul; 45 Suppl 3():S81-3. PubMed ID: 8674900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
    Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
    J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.
    Odani H; Shinzato T; Matsumoto Y; Usami J; Maeda K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):89-93. PubMed ID: 10066428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
    Niwa T; Katsuzaki T; Miyazaki S; Miyazaki T; Ishizaki Y; Hayase F; Tatemichi N; Takei Y
    J Clin Invest; 1997 Mar; 99(6):1272-80. PubMed ID: 9077536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of polyol pathway in nonenzymatic glycation.
    Hamada Y; Araki N; Horiuchi S; Hotta N
    Nephrol Dial Transplant; 1996; 11 Suppl 5():95-8. PubMed ID: 9044317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure.
    Sebeková K; Blazícek P; Syrová D; Krivosíková Z; Spustová V; Heidland A; Schinzel R
    Kidney Int Suppl; 2001 Feb; 78():S58-62. PubMed ID: 11168984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical detection of imidazolone in uremia and rheumatoid arthritis.
    Franke S; Niwa T; Deuther-Conrad W; Sommer M; Hein G; Stein G
    Clin Chim Acta; 2000 Oct; 300(1-2):29-41. PubMed ID: 10958861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
    Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
    Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.